Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.22.2
Consolidated Statements of Operations - USD ($)
12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Sales $ 33,765
Operating expenses:    
General and administrative 49,956,514 2,472,238
Research and development 407,874 79,550
Facility operations 1,922,049 403,029
Depreciation 1,307,038 346,437
Amortization 881,500
Total operating expenses 54,474,975 3,301,254
Net loss from operations (54,441,210) (3,301,254)
Other income (expense):    
Interest expense (726,243) (144,204)
Amortization of debt discount (2,616,364) (47,273)
Financing costs (1,904,074) (64,452)
Change in fair value of derivative liability (116,000) (29,000)
Change in fair value of warrant liability 1,987,000
Forgiveness of PPP loan 103,200
Gain on Vero Blue debt settlement 815,943
Legal Settlement (29,400,000)
Total other income (expense) (31,856,538) (284,929)
Loss before income taxes (86,297,748) (3,586,183)
Provision for income taxes
Net loss (86,297,748) (3,586,183)
Less net loss attributable to non-controlling interest (5,729)
Net loss attributable to NaturalShrimp Inc. (86,297,748) (3,580,454)
Amoritzation of beneficial conversion feature on Preferred shares (3,349,198) (1,720,833)
Accretion on Series D Preferred shares (337,834) (302,500)
Redemption and exchange of Series D Preferred shares (5,792,947)
Dividends (575,029) (317,083)
Net loss available for common stockholders $ (96,352,755) $ (5,920,870)
EARNINGS PER SHARE (Basic and diluted) $ (0.16) $ (0.01)
WEIGHTED AVERAGE SHARES OUTSTANDING (Basic and diluted) 619,123,768 501,477,593